update desk

Tel Aviv University develops tiny robot that can capture damaged cells

Innovative technology can transport targeted cells for analysis.

Tel Aviv University Professor Gilad Yossifon (fourth from left) and his research team. Credit: Courtesy.
Tel Aviv University Professor Gilad Yossifon (fourth from left) and his research team. Credit: Courtesy.

Researchers at Tel Aviv University have developed a “hybrid micro-robot” the size of a biological cell that is capable of capturing damaged cells, the institution announced on Sunday.

The tiny robot (10 microns, or 0.000393701 of an inch, across) can navigate between cells in a biological sample, carrying a targeted cell for study such as genetic analysis, the university said.

It can be controlled using two types of mechanisms: electric and magnetic.

The technology was developed by Professor Gilad Yossifon from the School of Mechanical Engineering and the Department of Biomedical Engineering and his research team.

“Developing the micro-robot’s ability to move autonomously was inspired by biological micro-swimmers such as bacteria and sperm cells. This is an innovative area of research that is developing rapidly, with a wide variety of uses in fields such as medicine and the environment, as well as a research tool,” said Yossifon.

Collaborators on the research included TAU post-doctoral researcher Yue Wu and student Sivan Yakov, along with Afu Fu, a post-doctoral researcher at the Technion-Israel Institute of Technology in Haifa.

The research was published in the journal Advanced Science.

“Among other things, the technology will support the following areas: medical diagnosis at the single cell level, introducing drugs or genes into cells, genetic editing, carrying drugs to their destination inside the body, cleaning the environment from polluting particles, drug development, and creating a ‘laboratory on a particle’—a microscopic laboratory designed to carry out diagnostics in places accessible only to micro-particles,” said Yossifon.

You have read 3 articles this month.
Register to receive full access to JNS.

Just before you scroll on...

Israel is at war. JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you. The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support? Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today
Topics
Comments
Thank you. You are a loyal JNS Reader.
You have read more than 10 articles this month.
Please register for full access to continue reading and post comments.
Never miss a thing
Get the best stories faster with JNS breaking news updates